Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

被引:186
作者
Fukuda, T
Hackman, RC
Guthrie, KA
Sandmaier, BM
Boeckh, M
Maris, MB
Maloney, DG
Deeg, HJ
Martin, PJ
Storb, RF
Madtes, DK
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Pulm Crit Care Med, Seattle, WA 98109 USA
[2] Univ Washington, Sch Med, Dept Pathol & Lab Med, Seattle, WA USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1182/blood-2003-05-1597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic pneumonia syndrome (IPS) is a significant noninfectious complication of hematopoietic stem cell transplantation (HSCT). We compared the incidences and outcomes of IPS among patients who underwent allogeneic HSCT after nonmyeloalblative (n = 183) compared with conventional (n = 917) conditioning between December 1997 and December 2001. Patients given nonmyeloalblative conditioning were older than those given conventional conditioning (median ages, 53 vs 41 years; P = .001). The cumulative incidence of IPS was significantly lower at 120 days after nonmyeloalblative conditioning than conventional conditioning (2.2% vs 8.4%; P = .003). In addition, greater patient age (older than 40 years), diagnosis of acute leukemia or myelodysplastic syndrome, and severe acute graft-versus-host disease were associated with significantly increased risks for IPS. Among older patients (older than 40 years) given conventional conditioning, high-dose total body irradiation (TBI) was associated with an increased risk for IPS than were non-TBI-based regimens (16% vs 5.8%; P = .001). IPS occurred early after transplantation, progressed rapidly, and was associated with a high mortality rate (75%) despite aggressive support. initiation of mechanical ventilation and the presence of renal insufficiency at IPS onset were associated with increased risks for death after IPS. These findings support the concept that lung damage from the conditioning regimen plays a crucial role in the development of IPS after HSCT. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:2777 / 2785
页数:9
相关论文
共 52 条
[1]   Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation [J].
Afessa, B ;
Litzow, MR ;
Tefferi, A .
BONE MARROW TRANSPLANTATION, 2001, 28 (05) :425-434
[2]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[3]   A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989 [J].
Atkinson, K ;
Nivison-Smith, I ;
Dodds, A ;
Concannon, A ;
Milliken, S ;
Downs, K .
BONE MARROW TRANSPLANTATION, 1998, 21 (07) :691-695
[4]   Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation [J].
Bach, PB ;
Schrag, D ;
Nierman, DM ;
Horak, D ;
White, P ;
Young, JW ;
Groeger, JS .
BLOOD, 2001, 98 (12) :3234-3240
[5]   Allogeneic marrow transplantation for multiple myeloma: An analysis of risk factors on outcome [J].
Bensinger, WI ;
Buckner, CD ;
Anasetti, C ;
Clift, R ;
Storb, R ;
Barnett, T ;
Chauncey, T ;
Shulman, H ;
Appelbaum, FR .
BLOOD, 1996, 88 (07) :2787-2793
[6]   Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation [J].
Boeckh, M ;
Bowden, RA ;
Storer, B ;
Chao, NJ ;
Spielberger, R ;
Tierney, DK ;
Gallez-Hawkins, G ;
Cunningham, T ;
Blume, KG ;
Levitt, D ;
Zaia, JA .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (06) :343-351
[7]   Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study [J].
Boeckh, M ;
Gooley, TA ;
Myerson, D ;
Cunningham, T ;
Schoch, G ;
Bowden, RA .
BLOOD, 1996, 88 (10) :4063-4071
[8]  
Boeckh M., 2002, Clinical Approach to Infection in the Compromised Host, P527
[9]  
BORTIN MM, 1982, LANCET, V1, P437
[10]   Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation [J].
Capizzi, SA ;
Kumar, S ;
Huneke, NE ;
Gertz, MA ;
Inwards, DJ ;
Litzow, MR ;
Lacy, MQ ;
Gastineau, DA ;
Prakash, UBS ;
Tefferi, A .
BONE MARROW TRANSPLANTATION, 2001, 27 (12) :1299-1303